5t31
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 5t31 is ON HOLD until | + | The entry 5t31 is ON HOLD until Feb 21 2019 |
Authors: Stein, A.J., Holson, E.B., Wagner, F.F., Cambell, A.J. | Authors: Stein, A.J., Holson, E.B., Wagner, F.F., Cambell, A.J. | ||
| Line 7: | Line 7: | ||
Description: Exploiting an Asp-Glu switch in Glycogen Synthase Kinase 3 to design paralog selective inhibitors for use in acute myeloid leukemia | Description: Exploiting an Asp-Glu switch in Glycogen Synthase Kinase 3 to design paralog selective inhibitors for use in acute myeloid leukemia | ||
[[Category: Unreleased Structures]] | [[Category: Unreleased Structures]] | ||
| + | [[Category: Holson, E.B]] | ||
[[Category: Wagner, F.F]] | [[Category: Wagner, F.F]] | ||
[[Category: Stein, A.J]] | [[Category: Stein, A.J]] | ||
| - | [[Category: Holson, E.B]] | ||
[[Category: Cambell, A.J]] | [[Category: Cambell, A.J]] | ||
Revision as of 13:20, 27 September 2017
Unreleased structure
The entry 5t31 is ON HOLD until Feb 21 2019
Authors: Stein, A.J., Holson, E.B., Wagner, F.F., Cambell, A.J.
Description: Exploiting an Asp-Glu switch in Glycogen Synthase Kinase 3 to design paralog selective inhibitors for use in acute myeloid leukemia
